STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.

Revenue
+8.79%
EPS
+12.8%
Free cash flow
+43.6%
Total debt
−0.21%

Quarter to September 2026, against a year earlier

253.19 0.93 −0.37%
Market cap
$24.8B
P/E
30.0×
Fwd P/E
25.1×
Dividend yield
1.02%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100

STERIS plc (STE) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, STERIS plc (STE) trades at a P/B ratio of 3.4×. Over the past ten years it has ranged from 1.5× (June 2016) to 7.4× (December 2019); the current reading is higher than 54% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2026 3.0× (10.68%)
FY2025 3.4× (2.31%)
FY2024 3.5× 10.37%
FY2023 3.1× (13.04%)
FY2022 3.6× (13.61%)
FY2021 4.2× 20.14%
FY2020 3.5× 2.62%
FY2019 3.4× 40.64%
FY2018 2.4× 13.85%
FY2017 2.1× 27.82%

Quarterly newest first

Period P/B ratio Change
Sep 2026 2.8× (1.26%)
Jun 2026 2.8× (5.67%)
Mar 2026 3.0× (13.13%)
Dec 2025 3.5× 0.17%
43 more quarters

Against its own ten years

Low 1.5× High 7.4×
Ten-year median 3.3×
Current reading's percentile 59

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on STE